Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P, Adeniji OS, Bordoloi D, Kinslow J, Martinson J, Parent DM, Hong KY, Koshy J, Kulkarni AJ, Zilberstein NF, Balk RA, Moy JN, Giron LB, Tracy RP, Keshavarzian A, Muthumani K, Landay A, Weiner DB, Abdel-Mohsen M. Saini P, et al. Among authors: moy jn. mBio. 2023 Feb 28;14(1):e0339322. doi: 10.1128/mbio.03393-22. Epub 2023 Feb 2. mBio. 2023. PMID: 36728420 Free PMC article.
Immune Dysregulation in Acute SARS-CoV-2 Infection.
Grimm L, Onyeukwu C, Kenny G, Parent DM, Fu J, Dhingra S, Yang E, Moy J, Utz PJ, Tracy R, Landay A. Grimm L, et al. Among authors: moy j. Pathog Immun. 2023 Feb 20;7(2):143-170. doi: 10.20411/pai.v7i2.537. eCollection 2022. Pathog Immun. 2023. PMID: 36865568 Free PMC article.
Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays.
Boler M, Anderson M, Rodgers M, Parumoottil J, Olivo A, Harris B, Stec M, Gosha A, Behun D, Holzmayer V, Anderson A, Greenholt E, Fortney T, Almaraz E, Cloherty G, Landay A, Moy J. Boler M, et al. Among authors: moy j. IJID Reg. 2023 Jun;7:277-280. doi: 10.1016/j.ijregi.2023.04.014. Epub 2023 May 12. IJID Reg. 2023. PMID: 37234563 Free PMC article.
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Leung JM, Wu MJ, Kheradpour P, Chen C, Drake KA, Tong G, Ridaura VK, Zisser HC, Conrad WA, Hudson N, Allen J, Welberry C, Parsy-Kowalska C, Macdonald I, Tapson VF, Moy JN, deFilippi CR, Rosas IO, Basit M, Krishnan JA, Parthasarathy S, Prabhakar BS, Salvatore M, Kim CC. Leung JM, et al. Among authors: moy jn. Front Immunol. 2024 Jan 22;15:1348041. doi: 10.3389/fimmu.2024.1348041. eCollection 2024. Front Immunol. 2024. PMID: 38318183 Free PMC article.
European Joint Programme on Rare Diseases workshop: LAMA2-muscular dystrophy: paving the road to therapy March 17-19, 2023, Barcelona, Spain.
Smeets H, Verbrugge B, Bulbena X, Hristova L, Vogt J, van Beckhoven I; all participants; Patient organizations/patient representatives: LAMA2-Europe, Voor Sara-the Netherlands, ImpulsaT-Spain, LAMA2-France, CMD-Turkey, LAMA2-Bulgaria, Cure-CMD. Smeets H, et al. Neuromuscul Disord. 2024 Mar;36:16-22. doi: 10.1016/j.nmd.2024.01.001. Epub 2024 Jan 9. Neuromuscul Disord. 2024. PMID: 38306718
Evaluation of the Panbio™ COVID-19 IgG rapid test device performance.
Moy JN, Amin AM, Chalmers-Watson C, Chowdhury R, Forssten C, Fu J, Ghosh S, Harris JD, Kordowich S, Li Y, Lin W, Mackay-Thomas S, Mickiewicz M, Patel N, Resino S, Sevenoaks T, Tugetman MA, Valencia J, Vijesurier R, White N, Woods CW, Kennedy PT, Ryan P. Moy JN, et al. Heliyon. 2023 Nov 22;9(12):e22612. doi: 10.1016/j.heliyon.2023.e22612. eCollection 2023 Dec. Heliyon. 2023. PMID: 38125420 Free PMC article.
250 results